BigOmics Analytics – Medium

BigOmics Analytics

BigOmics Analytics

Rheumatoid Arthritis: public data analysis with Omics Playground

Today we will take a look at a study on Rheumatoid Arthritis (RA) published in 2017 on Arthritis Research & Therapy using our Omics…

May 20, 2020

Rheumatoid Arthritis: public data analysis with Omics Playground

May 20, 2020

BigOmics Analytics

The Role of Vitamin C in Cancer Therapy

Today’s post was inspired by the following online blog post on the benefits of high intravenous vitamin C (aka ascorbate) doses in cancer…

May 15, 2020

The Role of Vitamin C in Cancer Therapy

May 15, 2020

BigOmics Analytics

Whole blood transcriptome changes following controlled human malaria infection

For Malaria day, we decided to re-analyse the data from a published article. The data is currently available on the public ARCHS4-omics…

Apr 25, 2020

Whole blood transcriptome changes following controlled human malaria infection

Apr 25, 2020

BigOmics Analytics

Part II: Potential Sars-CoV-2 Inhibitory drugs and biomarkers based on Blanco-Melo et al’s dataset

Using the “Enrichment” tab on the Viromics platform, we consulted the Drug Connectivity Map database to identify potentially inhibitory…

Apr 24, 2020

Part II: Potential Sars-CoV-2 Inhibitory drugs and biomarkers based on Blanco-Melo et al’s dataset

Apr 24, 2020

BigOmics Analytics

Part I: Re-analysis of the first public SARS-CoV-2 transcriptomics data from Blanco-Melo et. al.

The first public SARS-CoV-2 transcriptome is now available and we took the opportunity to upload it onto our platform for analysis. The…

Apr 14, 2020

Part I: Re-analysis of the first public SARS-CoV-2 transcriptomics data from Blanco-Melo et. al.

Apr 14, 2020

BigOmics Analytics

Brief re-analysis of SARS-CoV-2 proteomics from Bojkova et. al.

The first proteome of a SARS-CoV-2 in vitro infection has recently been published. The data set consists of a time series between 2h-24h…

Apr 3, 2020

Brief re-analysis of SARS-CoV-2 proteomics from Bojkova et. al.

Apr 3, 2020

BigOmics Analytics

Finding potential biomarkers and therapeutic drugs with coronavirus datasets — PT 2

Final conclusions of Axel Martinelli’s analysis.

Feb 25, 2020

Finding potential biomarkers and therapeutic drugs with coronavirus datasets — PT 2

Feb 25, 2020

BigOmics Analytics

Finding potential biomarkers and therapeutic drugs with Coronavirus datasets

Our company, Bigomics Analytics, recently launched the Viromics Playground, an open access online version of the Omics Playground platform…

Feb 19, 2020

Finding potential biomarkers and therapeutic drugs with Coronavirus datasets

Feb 19, 2020

BigOmics Analytics

Mining public datasets to address the Coronavirus epidemic

The current Coronavirus epidemic (COVID-19) has been causing widespread panic and has been a major health concern in the past months…

Feb 17, 2020

Credit: NIAID-RML.

Feb 17, 2020

BigOmics Analytics

BigOmics Analytics

BigOmics is a Swiss Start-Up, focused on helping life scientists see and understand their omics data by providing them with smart tools for advanced analyses.

Following

Help
Status
About
Careers
Press
Blog
Privacy
Terms
Text to speech
Teams